Oslo - Delayed Quote NOK
Oncoinvent ASA (ONCIN.OL)
1.6060
+0.0160
+(1.01%)
At close: May 16 at 4:16:32 PM GMT+2
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Oystein Soug M.Sc | Chief Executive Officer | 2.79M | -- | 1969 |
| Mr. Tore Kvam | Chief Financial Officer | 1.86M | -- | -- |
| Ms. Gro Elisabeth Hjellum | Chief Operating Officer | 2.03M | -- | -- |
| Ms. Kristine Lofthus | Chief Production Officer | 1.56M | -- | -- |
| Mr. Stian Brekke | Head of Regulatory Affairs | 1.45M | -- | -- |
| Dr. Kari Myren M.D. | Chief Medical Officer | 2.17M | -- | -- |
| Ms. Anne Cecile Alvik | Head of Quality Assurance & Employee Representative Director | 1.39M | -- | -- |
| Dr. Anne-Kirsti Aksnes Ph.D. | Chief Clinical Officer | 1.98M | -- | -- |
| Ms. Froydis Schulz | Head of Health Safety & Environment | -- | -- | -- |
| Ms. Ingjerd Eika | Head of Quality Control | -- | -- | -- |
Oncoinvent ASA
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 35
Description
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, alpha-radiation therapy candidate designed for the direct targeting of cancers that have spread to body cavities, like the peritoneum in two phase 1/2a trials and one randomized phase 2 trial. The company was incorporated in 2010 and is based in Oslo, Norway.
Corporate Governance
Oncoinvent ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ZLNA.OL Zelluna ASA
13.75
-1.06%
ABS.OL Arctic Bioscience AS
3.8500
+4.05%
CRNA.OL Circio Holding ASA
0.6270
-4.27%
PCIB.OL PCI Biotech Holding ASA
1.7600
-5.38%
LYTIX.OL Lytix Biopharma AS
7.60
-1.30%
BGBIO.OL BerGenBio ASA
1.7500
+2.58%
HURA TuHURA Biosciences, Inc.
3.9200
+2.08%
VRCA Verrica Pharmaceuticals Inc.
0.6623
+3.19%
VSTM Verastem, Inc.
7.59
-4.29%